Latest News and Press Releases

According to the settlement agreement, the proposed biosimilar to Eylea® (aflibercept) can be marketed in the U.S., if approved by the FDA, in the fourth quarter of 2026, or earlier under certain...

Notice to convene the Annual General Meeting on 21 January 2026 - RIAS A/S Attachment Notice to Convene the Annual General Meeting 21_01_2026 ...

ASUNCIÓN, Paraguay, Dec. 19, 2025 (GLOBE NEWSWIRE) -- In a crypto market still influenced by cycles of euphoria and correction, projects with verifiable backing, real infrastructure, and clear...

According to the settlement agreement, the proposed biosimilar to Eylea® (aflibercept) can be marketed in the U.S., if approved by the FDA, in the fourth quarter of 2026, or earlier under certain...

BEN received today the European Union type-approval certificate after a long and demanding process carried out at IDIADA (in Spain), and can now be driven

REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of...

Investor News 19 December 2025 The expected dates for release of Financial Reports and the Annual General Meeting of North Media A/S in 2026 are: 25 February 2026Annual Report 202510 April...

Stockholm, December 19th, 2025 - Virtune, a Swedish regulated digital asset manager is announcing the launch of a new innovative crypto ETP, Virtune Bittensor ETP, on Nasdaq Stockholm, the largest...

Selskabsmeddelelse nr. 21 – 2025København, den 19. december 2025 Meddelelse om tvangsindløsning og anmodning om afnotering af NTR Holding A/S’ B-aktier fra Nasdaq Copenhagen A/S Copenhagen Capital...

The company will publish information on its financial results on the following dates: 06 February 2026 Unaudited results for Q4 2025 and full year 2025 27 March 2026  Audited results for 2025,...